1. Home
  2. CRMD vs RA Comparison

CRMD vs RA Comparison

Compare CRMD & RA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMD
  • RA
  • Stock Information
  • Founded
  • CRMD 2006
  • RA 2016
  • Country
  • CRMD United States
  • RA United States
  • Employees
  • CRMD N/A
  • RA 1260
  • Industry
  • CRMD Biotechnology: Pharmaceutical Preparations
  • RA Investment Managers
  • Sector
  • CRMD Health Care
  • RA Finance
  • Exchange
  • CRMD Nasdaq
  • RA Nasdaq
  • Market Cap
  • CRMD 849.8M
  • RA 715.0M
  • IPO Year
  • CRMD 2010
  • RA N/A
  • Fundamental
  • Price
  • CRMD $13.18
  • RA $12.96
  • Analyst Decision
  • CRMD Strong Buy
  • RA
  • Analyst Count
  • CRMD 6
  • RA 0
  • Target Price
  • CRMD $15.00
  • RA N/A
  • AVG Volume (30 Days)
  • CRMD 1.7M
  • RA 280.8K
  • Earning Date
  • CRMD 05-06-2025
  • RA 01-01-0001
  • Dividend Yield
  • CRMD N/A
  • RA 14.73%
  • EPS Growth
  • CRMD N/A
  • RA N/A
  • EPS
  • CRMD 0.28
  • RA N/A
  • Revenue
  • CRMD $82,553,827.00
  • RA N/A
  • Revenue This Year
  • CRMD $238.38
  • RA N/A
  • Revenue Next Year
  • CRMD $53.52
  • RA N/A
  • P/E Ratio
  • CRMD $47.48
  • RA N/A
  • Revenue Growth
  • CRMD N/A
  • RA N/A
  • 52 Week Low
  • CRMD $3.61
  • RA $11.89
  • 52 Week High
  • CRMD $13.85
  • RA $17.32
  • Technical
  • Relative Strength Index (RSI)
  • CRMD 69.49
  • RA 54.45
  • Support Level
  • CRMD $11.88
  • RA $12.86
  • Resistance Level
  • CRMD $12.90
  • RA $12.95
  • Average True Range (ATR)
  • CRMD 0.55
  • RA 0.08
  • MACD
  • CRMD -0.07
  • RA 0.01
  • Stochastic Oscillator
  • CRMD 90.00
  • RA 84.00

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About RA Brookfield Real Assets Income Fund Inc.

Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. Its investment objective is to seek a high total return, through high current income and secondarily, through the growth of capital. The Fund seeks to achieve its investment objective by investing in the real asset class, which includes the following: Real Estate Securities; Infrastructure Securities; and Natural Resources Securities. The Firm manages separate accounts, registered funds, and opportunistic strategies for institutional and individual clients, including financial institutions, public and private pension plans, insurance companies, endowments and foundations, sovereign wealth funds, and high-net-worth investors.

Share on Social Networks: